Table 4.
Summary of absorption, distribution, metabolism, and elimination of curcumin.
| Model | Dose/Concentration | Main Finding | Ref | 
|---|---|---|---|
| Absorption | |||
| Caco-2 permeability assay | 20 μg/mL | Permeation rate 7.1 × 10−6 cm/s | (Yu and Huang, 2011) [168] | 
| Caco-2 permeability assay | 20 μg/mL | Permeation rate 8.4 × 10−6 cm/s | (Yu and Huang, 2012) [167] | 
| Reverted rat gut sacs | 100 μg/mL | Amount of curcumin in the serosal fluid of the jejunum > duodenum and ileum | (Y.-M. Tsai et al., 2012) [178] | 
| comparable amount of curcumin in sac tissue of duodenum, jejunum, and ileum | |||
| Caco-2 permeability assay | 30 μg/mL | Permeability coefficient 5.14 × 10−8 cm/s | (J. Wang et al., 2015) [166] | 
| In vivo biodistribtion in rats | 70 mg/kg | Curcumin was absorbed through intestinal segments, including the duodenum, jejunum, and ileum | |
| In situ single-pass intestinal perfusion test (SPIP) | 5 µg/mL curcumin | Permeability coefficient of curcumin in duodenum > jejunum and ileum | (H. Ji et al., 2016) [164] | 
| Rat intestinal perfusion study  | 
40 μg/mL curcumin | Absorption rate and effective permeability of curcumin in the duodenum > jejunum and ileum | (Tian, Asghar, Wu, Chen et al., 2017) [165] | 
| Distribution | |||
| Male albino rats | 400 mg curcumin | Portal blood, stomach, intestine, liver, and kidney | (Ravindranath and Chandrasekhara, 1980) [179] | 
| Female BALB/c mice | 100 mg/kg body weight, i.p | Plasma, liver, kidneys, spleen, brain, and intestines 1 h after i.p. administration | (Pan, Huang, and Lin 1999) [171] | 
| Male Wistar albino rats | 340 mg/kg | Intestinal mucosa, liver, kidney, and heart | (Marczylo, Steward, and Gescher 2009) [174] | 
| Male ICR mice | 20 and 400 mg/kg. p.o. | Plasma and central nervous system (brain and spinal cord) | (Szymusiak et al., 2016) [87] | 
| Metabolism (metabolites) | |||
| In vitro: hepatocytes or liver microsomes | 0.1–5 μg/mL | 60%–90% of curcumin was metabolized within 30 min | (Wahlström and Blennow 1978) [176] | 
| In vitro hepatocytes | 100 μM | Hexahydrocurcumin and hexahydrocurcuminol | (Ireson et al., 2001) [172] | 
| Male Sprague–Dawley rats | 0.6–12 mg, i.v | glucuronides of tetrahydrocurcumin and Hexahydrocurcumin, dihydroferulic acid, and ferulic acid | (Holder, Plummer, and Ryan 1978) [173] | 
| Female BALB/c mice | 100 mg/kg body weight, i.p | Curcumin-glucuronoside, dihydrocurcumin-glucuronoside, tetrahydrocurcumin-glucuronoside, and tetrahydrocurcumin | (Pan, Huang, and Lin 1999) [171] | 
| Female F344 rats | 500 mg/kg, p.o and  40 mg/kg, i.v.  | 
Major: curcumin glucuronide and curcumin sulfate minor: hexahydrocurcumin, hexahydrocurcuminol, hexahydrocurcumin glucuronide  | 
(Ireson et al., 2001) [172] | 
| Male Wistar albino rats | 340 mg/kg, p.o. | Phenolic glucuronides and alcoholic glucuronides (plasma and urine) | (Marczylo, Steward, and Gescher 2009) [174] | 
| Human | Curcuminoids, 3.6 g/d for 29 days, p.o | Curcumin glucuronide and curcumin sulfate (plasma and urine) | (R.A. Sharma et al., 2004) [177] | 
| Elimination | |||
| Sprague–Dawley rats | 1 g/kg | 75% of curcumin excreted in the feces, the undetectable amount in urine | (Wahlström and Blennow 1978) [176] | 
| Sprague–Dawley rats | 0.6 mg/dose | -[3H]-curcumin metabolites—89.4% (feces) 6.3% (urine) | (Holder, Plummer, and Ryan 1978) [173] | 
| High extent of biliary excretion of curcumin | |||
| Male Wistar albino rats | 340 mg/kg, p.o. | 2.0 ng/mL of curcumin (urine) | (Marczylo, Steward, and Gescher 2009) [174] | 
| Human | Curcumuminoids, 3.6 g/d for 29 days, p.o | Curcumin and its metabolites (urine and feces) | (R.A. Sharma et al., 2004) [177] |